Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 29 studies | 45% ± 17% | |
smooth muscle cell | 24 studies | 47% ± 17% | |
endothelial cell | 21 studies | 32% ± 15% | |
fibroblast | 20 studies | 33% ± 17% | |
myofibroblast cell | 10 studies | 42% ± 26% | |
connective tissue cell | 10 studies | 35% ± 18% | |
vein endothelial cell | 10 studies | 28% ± 9% | |
endothelial cell of vascular tree | 10 studies | 37% ± 16% | |
basal cell | 8 studies | 29% ± 15% | |
epithelial cell | 5 studies | 39% ± 16% | |
abnormal cell | 4 studies | 25% ± 9% | |
endothelial cell of artery | 4 studies | 21% ± 3% | |
mesothelial cell | 4 studies | 48% ± 3% | |
capillary endothelial cell | 4 studies | 25% ± 7% | |
ciliated cell | 4 studies | 36% ± 9% | |
Mueller cell | 4 studies | 35% ± 19% | |
kidney loop of Henle epithelial cell | 3 studies | 29% ± 5% | |
epithelial cell of proximal tubule | 3 studies | 22% ± 7% | |
placental villous trophoblast | 3 studies | 44% ± 13% | |
endothelial cell of lymphatic vessel | 3 studies | 24% ± 5% | |
astrocyte | 3 studies | 38% ± 14% | |
neuron | 3 studies | 26% ± 7% | |
muscle cell | 3 studies | 55% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 99% | 2318.86 | 169 / 170 | 94% | 35.82 | 431 / 459 |
thymus | 100% | 2089.64 | 650 / 653 | 92% | 10.71 | 556 / 605 |
prostate | 100% | 1965.47 | 244 / 245 | 85% | 12.42 | 425 / 502 |
brain | 85% | 827.81 | 2240 / 2642 | 98% | 59.90 | 693 / 705 |
kidney | 100% | 2186.76 | 89 / 89 | 82% | 17.20 | 735 / 901 |
esophagus | 100% | 3045.36 | 1444 / 1445 | 75% | 13.42 | 137 / 183 |
lung | 99% | 2188.64 | 575 / 578 | 75% | 12.80 | 865 / 1155 |
bladder | 100% | 1843.33 | 21 / 21 | 71% | 10.35 | 357 / 504 |
breast | 100% | 2062.32 | 457 / 459 | 68% | 8.32 | 759 / 1118 |
liver | 84% | 856.49 | 189 / 226 | 78% | 12.18 | 317 / 406 |
ovary | 83% | 1089.02 | 149 / 180 | 72% | 9.06 | 310 / 430 |
stomach | 97% | 1405.67 | 350 / 359 | 39% | 3.74 | 112 / 286 |
intestine | 94% | 1303.81 | 905 / 966 | 39% | 2.97 | 207 / 527 |
skin | 73% | 638.88 | 1325 / 1809 | 45% | 7.58 | 212 / 472 |
pancreas | 31% | 186.18 | 102 / 328 | 83% | 7.87 | 147 / 178 |
blood vessel | 100% | 8461.40 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.16 | 45 / 45 |
adipose | 100% | 2301.19 | 1199 / 1204 | 0% | 0 | 0 / 0 |
spleen | 83% | 706.23 | 200 / 241 | 0% | 0 | 0 / 0 |
heart | 70% | 573.62 | 607 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 13% | 77.48 | 34 / 258 | 32% | 4.33 | 73 / 230 |
muscle | 28% | 183.09 | 228 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.56 | 7 / 29 |
eye | 0% | 0 | 0 / 0 | 5% | 0.62 | 4 / 80 |
peripheral blood | 1% | 8.77 | 13 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060537 | Biological process | muscle tissue development |
GO_0045214 | Biological process | sarcomere organization |
GO_0030154 | Biological process | cell differentiation |
GO_0005925 | Cellular component | focal adhesion |
GO_0030018 | Cellular component | Z disc |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042805 | Molecular function | actinin binding |
GO_0005515 | Molecular function | protein binding |
GO_0008307 | Molecular function | structural constituent of muscle |
GO_0003674 | Molecular function | molecular_function |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CSRP2 |
Protein name | Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2) (CRP2) (LIM domain only protein 5) (LMO-5) (Smooth muscle cell LIM protein) (SmLIM) Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2) |
Synonyms | SMLIM LMO5 hCG_27233 |
Description | FUNCTION: Drastically down-regulated in response to PDGF-BB or cell injury, that promote smooth muscle cell proliferation and dedifferentiation. Seems to play a role in the development of the embryonic vascular system. |
Accessions | ENST00000311083.10 A0A024RBB5 Q16527 F8VW96 ENST00000552330.5 F8VQR7 ENST00000547435.1 ENST00000546966.5 |